FacebookTwitterDiggGoogle BookmarksRedditRSS Feed

Articles

The FDA annouced on July 6th, that Stryker has announced a voluntary recall of its modular neck stems used in its hip replacement products. 

"While modular-neck stems provide surgeons with an option to correct certain aspects of a patient’s anatomy and hip biomechanics, given the potential risks associated with fretting and corrosion at the modular neck junction, Stryker Orthopaedics decided to take this voluntary action," said Stuart Simpson, Vice President and General Manager, Hip Reconstruction.

Stryker Orthopaedics’ decision to voluntarily remove Rejuvenate and ABG II modular-neck stems and terminate global distribution of these products comes after continued post-market surveillance. The post-market surveillance data may be predictive of a trend. "Following this action, we will work with the medical community to better understand this matter as we continue to evaluate the data," said Simpson.

Stryker has notified healthcare professionals and regulatory bodies of this voluntary recall. Patients who received a Rejuvenate Modular or ABG II modular-neck stem are encouraged to contact their surgeon. Patients uncertain if they have one of these products implanted should contact their surgeon or consult their medical records.

Learn more about this Hip Recall and how it may effect you on our Stryker Hip Recall page.

Lawsuit Evaluation Form

Please provide us as much information as possible concerning the problems you are experiencing.

Evaluation Information

Please indicate the name of the drug or device. The more details the better.

What were the side effects?

Important Legal Disclaimer*

 

 

 

Our e-Newsletter

Stay up to date with the latest alerts, recalls and other useful information from RecallWarning by signing up to our free e-newsletter.

Latest FDA Alerts

call_to_action

Random Articles




DMCA.com